A Clinical Study of Lyophilized Plasma in Patients on Warfarin

Status Withdrawn

Clinical Trial Summary

This is a multi center, phase 2 randomized controlled study to determine the effect of lyophilized plasma in patients on warfarin therapy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Anticoagulant Therapy

Clinical Trial Details

NCT number	NCT01541098
Study type	Interventional
Source	HemCon Medical Technologies, Inc
Contact
Status	Withdrawn
Phase	Phase 2
Start date	January 2015
Completion date	January 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05361889` - ReAl-life multIceNter Outcomes Registry for Better antithrOmbotic Strategies in Patients With AF (RAINBOW-AF)
Completed	`NCT03143569` - Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial	N/A
Recruiting	`NCT05486351` - Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
Completed	`NCT04623177` - Thromboprophylaxis for Patients in ICU With COVID-19
Active, not recruiting	`NCT05491460` - Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects	Phase 1
Completed	`NCT04351438` - Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
Recruiting	`NCT05181774` - Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics
Completed	`NCT03182829` - In Vitro Diagnostic Test for DOAC in Urine